<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1400074&amp;fmt=gif">

Product overview

Deciphering the complexity of cancer.

Working alongside clinicians, we boldly question the status quo and employ personalized and integrated approaches to uncover new solutions to diagnostic challenges.

A focus on the continuum of lung cancer care

Early Detection

Early detection of lung cancer can decrease lung cancer-related mortality by up to 20 percent1. We are committed to providing diagnostic solutions that support early identification of lung cancer.



With more than 1.6 million nodules detected incidentally each year2, clinical lung cancer risk assessment has become a critical component of managing patients.  The Nodify XL2 test is designed to help physicians stratify patients with incidental lung nodules by risk of malignancy.

Learn more about Nodify XL2

Treatment Strategy

We strive to transform lung cancer standards by equipping clinicians with the right information at the right time. Biodesix Lung Reflex® testing delivers integrated blood-based genomic and proteomic results within 72-hours, expediting time to treatment.

Learn more about Biodesix Lung Reflex®


Each patient responds to cancer and treatment uniquely.  Our blood-based testing solutions provide a personalized view of each patient's evolving disease state, which can help inform treatment strategy.

Learn more about Biodesix Lung Reflex®

Innovation & Discovery

Using a technology agnostic approach, we provide our biopharma partners with end-to-end diagnostic solutions from initial biomarker discovery projects to companion diagnostic partnering, including commercialization and reimbursement. 

Learn more about our Biopharma Solutions 


Order a test kit


Data library

Discover more
  1. American Lung Association. “Lung Cancer Fact Sheet,” 14 Dec 2018. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet.html.[Accessed 12 Aug 2019]
  2. Gould et al, "Recent Trends in the Identification of Incidental Pulmonary Nodules," American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 10, 2015.